For subscribers
Not all newly approved drugs provide real benefits to patients
Sign up now: Get ST's newsletters delivered to your inbox
Drugs and treatments make it to the Cancer Drug List if they are both effective and provide value for money.
PHOTO ILLUSTRATION: ST FILE
Follow topic:
SINGAPORE - The Agency for Care Effectiveness (ACE) is not just assessing the relative merit of drugs, but also doing its bit to stop insurance premiums from spiking out of reach.
It was in the limelight recently for its Cancer Drug List (CDL). From September 2022, MediShield Life and MediSave stopped covering treatments not on the list.
